Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

NICE issues new draft guidance on epilepsy

GPs should never initiate anti-epilepsy drug treatment without the recommendation of a specialist, according to new draft guidance from the National Institute for Clinical Excellence.

The draft guidance ­ which follows a damning national audit on epilepsy services by NICE last May ­ says continuing responsibility for prescribing can be taken by GPs but a specialist should always be involved in the initial treatment decision.

The guidance urged GPs to review epilepsy patients at least annually, including an inquiry about side-effects and compliance with treatment plans.

But indiscriminate, regular monitoring of anti-epilepsy drug blood levels is not recommended and should only be considered in specific circumstances such as pregnancy.

Dr David Finnigan, a Newcastle GP and member of the group that wrote the guidance, said the advice complemented the epilepsy care targets in the new contract.

He added: 'Anything that pulls together the evidence base for different types of treatment, patient information and follow-up monitoring is helpful. There has been a lot of uncertainty out there.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say